A comprehensive review of influenza B virus, its biological and clinical aspects
Frontiers in Microbiology · 04.09.2024 · 15
DOI: 10.3389/fmicb.2024.1467029 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 04.09.2024. Verfasst von Muhammad Awais Ashraf und 9 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Molecular Virology and Immunology, Institutional Center for Shared Technologies and Facilities, Pathogen Discovery and Big Data…. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Influenza B virus (IBV) stands as a paradox, often overshadowed by its more notorious counterpart, influenza A virus (IAV). Yet, it remains a captivating and elusive subject of scientific inquiry. Influenza B is important because it causes seasonal flu outbreaks that can lead to severe respiratory illnesses, including bronchitis, pneumonia, and exacerbations of chronic conditions like asthma. Limitations in the influenza B virus’s epidemiological, immunological, and etiological evolution must be addressed promptly. This comprehensive review covers evolutionary epidemiology and pathogenesis, host-virus interactions, viral isolation and propagation, advanced molecular detection assays, vaccine composition and no animal reservoir for influenza B virus. Complex viral etiology begins with intranasal transmission of influenza B virus with the release of a segmented RNA genome that attacks host cell machinery for transcription and translation within the nucleus and the release of viral progeny. Influenza B virus prevalence in domesticated and wild canines, sea mammals, and birds is frequent, yet there is no zoonosis. The periodic circulation of influenza B virus indicates a 1–3-year cycle for monophyletic strain replacement within the Victoria strain due to frequent antigenic drift in the HA near the receptor-binding site (RBS), while the antigenic stability of Yamagata viruses portrays a more conservative evolutionary pattern. Additionally, this article outlines contemporary antiviral strategies, including pharmacological interventions and vaccination efforts. This article serves as a resource for researchers, healthcare professionals, and anyone interested in the mysterious nature of the influenza B virus. It provides valuable insights and knowledge essential for comprehending and effectively countering this viral foe, which continues to pose a significant public health threat.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CAS Key Laboratory of Molecular Virology and Immunology, Institutional Center for Shared Technologies and Facilities, Pathogen Discovery and Big Data Platform, Shanghai Institute of Immunity and Infection, Chinese Acade…
- University of Chinese Academy of Sciences, Beijing, China.
- Pediatric Department, Nanxiang Branch of Ruijin Hospital, Shanghai, China.
Zitieren
APA
Ashraf, M. A., Raza, M. A., Amjad, M. N., Ud Din, G., Yue, L., Shen, B., Chen, L., Dong, W., Xu, H., & Hu, Y. (2024). A comprehensive review of influenza B virus, its biological and clinical aspects. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1467029
Vancouver
Ashraf MA, Raza MA, Amjad MN, Ud Din G, Yue L, Shen B, et al. A comprehensive review of influenza B virus, its biological and clinical aspects. Frontiers in Microbiology. 2024;15. doi:10.3389/fmicb.2024.1467029
BibTeX
@article{Ashraf2024,
author = {Ashraf, Muhammad Awais and Raza, Muhammad Asif and Amjad, Muhammad Nabeel and Ud Din, Ghayyas and Yue, Lihuan and Shen, Bei and Chen, Lingdie and Dong, Wei and Xu, Huiting and Hu, Yihong},
title = {A comprehensive review of influenza B virus, its biological and clinical aspects},
journal = {Frontiers in Microbiology},
year = {2024},
volume = {15},
doi = {10.3389/fmicb.2024.1467029}
}
EUVIMED